Innate Immunity in Cancer Biology and Therapy

Immunotherapies including adaptive immune checkpoint inhibitors (ICIs) and chimeric antigen receptor (CAR) T cells, have developed the treatment of cancer in clinic, and most of them focus on activating T cell immunity. Although these strategies have obtained unprecedented clinical responses, only l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuxia, Xue, Wenjing, Xu, Caili, Nan, Yanyang, Mei, Shuang, Ju, Dianwen, Wang, Shaofei, Zhang, Xuyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379825/
https://www.ncbi.nlm.nih.gov/pubmed/37510993
http://dx.doi.org/10.3390/ijms241411233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379825/
https://www.ncbi.nlm.nih.gov/pubmed/37510993
http://dx.doi.org/10.3390/ijms241411233

Ejemplares similares